National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 183 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome



Case Details

This is page 7 out of 19

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16   next


VAERS ID: 1378479 (history)  
Form: Version 2.0  
Age: 58.0  
Sex: Female  
Location: Illinois  
Vaccinated:2021-04-10
Onset:2021-04-20
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-06-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 042A21A / N/A LA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Angiogram, Aphasia, Arthralgia, Balance disorder, CSF protein increased, Central venous catheterisation, Feeding disorder, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Intensive care, Lumbar puncture abnormal, Magnetic resonance imaging normal, Musculoskeletal disorder, Neck pain, Pain, Pain in extremity, Paraesthesia, Plasmapheresis, Sensory loss, Swelling face, Weight bearing difficulty
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Angioedema (narrow), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dementia (broad), Embolic and thrombotic events, venous (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Vestibular disorders (broad), Hypersensitivity (narrow), Arthritis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 13 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: April 21, 2021 - CT w/Angio and MRI completed - unremarkable April 24, 2021 - Lumbar Puncture showed elevated protein levels in CSF
CDC Split Type:

Write-up: Radiating pain from the right neck, shoulder and arm that spread to the left side. Tingling sensation in fingers, along with pain. Taken to ED, labs and imaging were done that were inconclusive. Tingling and numbness spreading to feet and legs, but however patient was discharged even in worsening condition with no answers, and told to make an appointment with a neurologist the following week. After being brought home, the numbness spread and patient could not support her weight and would lose balance. Ambulance called and taken back to the same facility. Admitted under observation initially, the following day, a lumbar puncture was completed, at the request from our daughter (who is a nurse) to the doctors, that showed elevated protein in the CSF. It was concluded that patient showed clinical signs of Guillian-Barre Syndrome and was subsequently started on IVIG therapy. Her condition worsened and she was upgraded to progressive care and then the neuro ICU when numbness had spread to her face. A central line was placed and patient was started on plasmapheresis. Patient showed loss of feeling and function in her arms and legs, swelling in her face that did not allow her to speak or eat properly. 3 more rounds of IVIG were done after plasmapheresis was completed. Patient was stabilized and transferred to the rehabilitation hospital for rehab and therapy.


VAERS ID: 1382577 (history)  
Form: Version 2.0  
Age: 55.0  
Sex: Male  
Location: Washington  
Vaccinated:2021-05-11
Onset:2021-05-26
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-06-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: CSF protein increased, Guillain-Barre syndrome, Magnetic resonance imaging head, Magnetic resonance imaging spinal abnormal, Muscular weakness, Plasmapheresis
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 9 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: Alcohol use Chronic back pain (history of L4-5 laminectomy in 1991)
Allergies: No known allergies
Diagnostic Lab Data: MRI brain and complete spine with hyperattentuation CSF with protein $g 500 Please note: patient is still in hospital at time of the filing. Currently on hospital day 9.
CDC Split Type:

Write-up: Weakness of lower extremities and arms that started around 5/26 and progressed over the next week until admission on 5/31. MRI brain and spine with diffuse enhancement and CSF with protein $g 500. Started on PLEX for presumed Guillan Barre Syndrome. He is slowly improving after 4 sessions.


VAERS ID: 1388426 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Male  
Location: Alabama  
Vaccinated:2021-04-09
Onset:2021-04-28
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808982 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Asthenia, Basophil count, CSF culture, CSF glucose normal, Eosinophil count, Guillain-Barre syndrome, Haematocrit, Haemoglobin, Immunoglobulin therapy, Lumbar puncture, Lymphocyte count, Magnetic resonance imaging spinal, Mean cell haemoglobin, Mean cell haemoglobin concentration, Mean cell volume, Mean platelet volume, Monocyte count, Neutrophil count, Pain in extremity, Platelet count, Red blood cell count, Red cell distribution width, Rhabdomyolysis, White blood cell count
SMQs:, Rhabdomyolysis/myopathy (narrow), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Tendinopathies and ligament disorders (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations: Shingles Vaccine
Other Medications: Lisinopril, Lipitor, and Amlodipine
Current Illness: Hypertension
Preexisting Conditions: Hypertension
Allergies: No known allergies
Diagnostic Lab Data: MRI L spine 4/28/21 Lumbar puncture CSF culture 4/27/21 WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, PLT, MPV, NEU, LYM, MON, EOS, BAS 4/28/21 CSFGLU 74 4/27/21
CDC Split Type:

Write-up: Admitted with c/o generalized weakness and significant pain to BLE s/p J and J vaccination. Neurology diagnosed pt with Guillain-Barre syndrome and is s/p IVIG and steroids''. Pt improved with IVIG and steroids''. Of note pt. states he has been to the hospital multiple times with these symptoms and told he had rhabdomyolysis 2/2 statin use therefore it was d/c on prior evaluations and he was d/c home. Further evaluation showed pt has Guillain-Barre syndrome.


VAERS ID: 1389044 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Male  
Location: Maryland  
Vaccinated:2021-04-08
Onset:2021-05-17
   Days after vaccination:39
Submitted: 0000-00-00
Entered: 2021-06-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 202A21A / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Asthenia, Dysstasia, Fall, Gait disturbance, Guillain-Barre syndrome, Magnetic resonance imaging abnormal, Muscular weakness, Paraesthesia, Weight bearing difficulty
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Demyelination (narrow), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 13 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient has had intermittent weakness since covid vaccine in April. Admitted on May 11 for weakness, stroke was ruled out. Noted to have bilateral upper and lower extremity paresthesia thought secondary to diabetes. Readmitted on May 17, began to have frequent falls with bilateral lower extremity weakness, when he stood up his legs could not hold him. MRI ruled out ischemic infarction. Diagnosed with Guillain-Barre disease and ambulatory weakness. Followed up with neurologist.


VAERS ID: 1391320 (history)  
Form: Version 2.0  
Age: 51.0  
Sex: Male  
Location: Maryland  
Vaccinated:2021-04-11
Onset:2021-04-26
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-06-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 202A21A / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Electromyogram, Guillain-Barre syndrome, Laboratory test, Lumbar puncture, Magnetic resonance imaging head, Magnetic resonance imaging neck, Magnetic resonance imaging spinal, Nerve conduction studies, Paraesthesia
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: Lumbar Puncture, MRI brain, Cervical neck, Lumbar spine, NCT/EMG, many serum lab tests. Way to much to include here as was admitted for 7 days for work up
CDC Split Type:

Write-up: gradual onset of paresthesias beginning exactly 14 days after vaccine administration. patient was then admitted to hospital on 5/22 when symptoms worsened and he was ultimately diagnosed with Guilliam Barre Syndrome.


VAERS ID: 1405260 (history)  
Form: Version 2.0  
Age: 46.0  
Sex: Female  
Location: Colorado  
Vaccinated:0000-00-00
Onset:2021-05-01
Submitted: 0000-00-00
Entered: 2021-06-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 201A21A / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Blood test, Computerised tomogram, Fatigue, Guillain-Barre syndrome, Hypoaesthesia, Limb injury, Muscular weakness, Paralysis, Peripheral swelling
SMQs:, Rhabdomyolysis/myopathy (broad), Cardiac failure (broad), Angioedema (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Accidents and injuries (narrow), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: The patient had no known allergies.
Allergies:
Diagnostic Lab Data: Test Date: 202106; Test Name: Blood test; Result Unstructured Data: Positive; Comments: Blood work to determine gullain barre syndrome; Test Date: 20210604; Test Name: CAT scan; Result Unstructured Data: Negative for blood clots
CDC Split Type: USJNJFOC20210627550

Write-up: FELT PARALYSED; DIAGNOSED WITH GUILLEN BARRE SYNDROME; INJURED RIGHT FOOT; NUMBNESS IN FACE; LEFT LEG WEAKNESS; SWELLING IN LEGS; TIREDNESS; FEELINGS OF WEAKNESS; NUMBNESS IN LEFT HAND; This spontaneous report received from a consumer concerned a 46 year old female. The patient''s weight was 113 kilograms, and height was 66 inches. The patient''s pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 201A21A, and expiry: 07-AUG-2021) dose was not reported, administered on 01-MAY-2021 to left arm for prophylactic vaccination. Concomitant medications included immunoglobulin human normal for guillen barre syndrome. On 01-MAY-2021, the subject experienced feelings of weakness, numbness in left hand. On 28-MAY-2021, the subject experienced tiredness. On 29-MAY-2021, the subject experienced left leg weakness and swelling in legs. On 02-JUN-2021, the subject experienced numbness in face. On 09-JUN-2021, the subject experienced diagnosed with guillen barre syndrome, and was hospitalized. On an unspecified date, the subject experienced injured right foot, and felt paralysed, and was hospitalized on 08-Jun-2021. On 01-MAY-2021, the patient developed numbness in her hand on the left side and felt weak. The patient travelled overseas and had a connection to a country and her husband stated that she started to have swelling in her legs. When she reached her destination, she was admitted to the hospital and was diagnosed with Guillen Barre Syndrome by the neurologist per her husband''s recollection. In the hospital she was given Immunoglobulin G for 5-7 days and she did regain some feeling in her legs. Based on patient''s husband recollection this may have occurred "maybe tired due to travelling," but when she arrived to the country that was when her left leg weak and requested a wheelchair. The patient then injured her "right foot" in another country, but "she didn''t feel it and she requested help because she couldn''t walk." per her husband. After she reached her final destination, she felt tired and then she completely fell. It was reported that she could not "control herself and felt paralyzed." On 08-JUN-2021, she entered the hospital and was still in hospital at the time of this report. Her husband states that he "does not know any side effect from any vaccine" that caused this in the past. Lastly, he mentioned "she may have numbness in her face when she reached original country". He also stated that the on 04-JUN-2021, doctors conducted a computerized tomography scan and did not find a blood clot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the feelings of weakness, swelling in legs, diagnosed with guillen barre syndrome, numbness in left hand, tiredness, left leg weakness, numbness in face, injured right foot and felt paralysed was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender''s Comments: V0: This is a spontaneous report received from consumer concerning a 46 year old female, unknown ethnicity, who experienced weakness and numbness of the left hand on the same day after receiving the Janssen Covid-19 vaccine and was diagnosed with Guillain-Barre Syndrome 39 days after. Patient''s height was 66 inches and weight was 113 kilograms. Past medical, previous surgery, current illnesses and medications taken as well as history of allergy, smoking, drug abuse and alcohol abuse were not reported. On the same day as the vaccine was given, patient developed weakness and numbness on the left hand. Patient still travelled. Twenty-eight (28) days post vaccine, patient experienced left leg weakness and swelling on the legs. Patient was noted to feel tired the day before. Thirty-two (32) days post vaccine, patient developed numbness on the face. Computerized Tomography (CT) scan was done and there was no blood clot found. Thirty-eight (38) days post vaccine, patient felt ''paralyzed'' and injured her right foot. Patient was brought to the hospital the following day and was subsequently admitted. Patient was diagnosed with Guillain-Barre Syndrome and was given IVIG. Information regarding other potential etiologies was insufficient. Considering the temporal relationship, the event is assessed to have an indeterminate relationship with vaccination.


VAERS ID: 1413336 (history)  
Form: Version 2.0  
Age: 43.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2021-03-31
Onset:2021-04-02
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-06-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 042A21A / 1 RA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Blood sodium decreased, Blood test normal, Bradycardia, Chest X-ray normal, Chest pain, Computerised tomogram thorax normal, Dyskinesia, Dyspnoea, Electrocardiogram normal, Fibrin D dimer increased, Full blood count normal, Gastrooesophageal reflux disease, Guillain-Barre syndrome, Head discomfort, Heart rate increased, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture, Magnetic resonance imaging head normal, Magnetic resonance imaging neck, Magnetic resonance imaging spinal normal, Metabolic function test, Musculoskeletal stiffness, Nasal discomfort, Nervous system disorder, Neurological examination, Pain, Pain in extremity, Paraesthesia, Postural orthostatic tachycardia syndrome, Presyncope, Protein total increased, SARS-CoV-2 test negative, Spinal X-ray normal, Tachycardia, Throat irritation, Tremor, Troponin normal, Ultrasound Doppler normal
SMQs:, Anaphylactic reaction (broad), Peripheral neuropathy (narrow), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dyskinesia (narrow), Dystonia (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific dysfunction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Hyponatraemia/SIADH (narrow), Cardiomyopathy (broad), Demyelination (narrow), Hypotonic-hyporesponsive episode (broad), Chronic kidney disease (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Dehydration (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 8 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Multivitamin, probiotic, occasional over the counter pain relief as needed (Tylenol, ibuprofen)
Current Illness: None
Preexisting Conditions: None
Allergies: Delayed skin reaction to CT contrast dye
Diagnostic Lab Data: 4/16 - CBC and metabolic panel; nothing notable, slightly low sodium 4/19 - spine X-ray - unremarkable; numerous blood tests, all normal, sodium back in range 4/22 - metabolic panel, normal; spinal MRI NORMAL 4/26 - EKG; numerous blood tests, all normal 4/27 - troponin normal; d dimer 866; Covid test negative; CT for pulmonary embolism negative 4/28 - CBC, troponin, metabolic panel, EKG all normal or close to range 4/29 - MRI head, cervical spine, and thoracic spine ; all came back no adverse findings 4/30 - lumbar puncture - tested for many things , but protein came back elevated ; led to GBS diagnosis 5/23 - many blood tests - d dimer elevated again at 1546; ultrasound for DVT negative for clots 5/24 - d dimer 1693; no other symptoms of PE so Ct/ VQ scan not recommended; orthostatics tested and showed increase of 30+ bpm upon standing 5/28 - numerous blood tests ; d dimer going down but still elevated at 1496 5/31 - numerous blood tests - normal or close to for all 6/14 - numerous blood tests all normal or close to 6/17 - chest X-ray normal
CDC Split Type:

Write-up: After receiving the vaccine on 3/31, experienced typical side effects noted such as sore arm, body aches, etc. - however two days after felt numbness and tingling in feet and hands which went away a few days later. On 4/14, the tingling in feet returned. Went to ER on 4/16 as tingling/numbness getting worse and progressing upward to legs; evaluated and sent home. Returned to ER on 4/22 as numbness/tingling continued to progress upward, evaluated and sent home. On 4/25, in addition to constant numbness/tingling, started experiencing tachycardia. Resting heart rate as well as heart rate doing simple tasks was high. Also began experiencing difficulty getting a full breath. Woke up 4/27 to worsening breathing and tachycardia, as well as new feelings of adrenaline rushes and Internal tremors throughout the body. PCP ordered Troponin and D Dimer and D Dimer elevated. Back to ER that day - negative Covid test - CT of chest showed no blood clots; sent home. That evening, resting heart rate was high and elevated even while lying down (90-110 bpm). The next day, 4/28, all symptoms continued and worsened as day progressed. Returned to ER and in the way experienced a pre syncope episode - upon arrival to ER blood pressure was 70/30; stabilized and sent home. Continued tachycardia and another pre-syncope episode that evening. Was referred to neurology and had appointment 4/29; all symptoms remained and were increasingly debilitating. Neurologist determined more testing needed, and was admitted to the hospital for observation/testing. Diagnosed with Guillain Barre Syndrome after head/neck/spine MRI and lumbar puncture, which showed elevated protein. Hospitalized for 5 day course of IVIG and discharged 5/4. Started feeling better for a few weeks, although numbness/tingling in legs/feet never went away. The week of 5/17 started feeling burning in throat/nose/chest and returning tachycardia; returned to ER 5/23, was admitted for observation as D Dimer high again - checked for DVT, all clear; testing and suspicion of Postural Orthostatic Tachycardia Syndrome (POTS); discharged 5/25. On evening of 5/30, experienced new concerning neurological tremors and sudden involuntary movements, as well as stiff neck/head. Returned to ER 5/31; evaluated and released. Have continued to experience autonomic nervous system dysfunction, POTS symptoms, tachycardia and bradycardia, constant numbness and tingling in extremities and occasional tingling/numbness in other areas in the body, pressure in head, internal tremors, adrenaline rushes, feelings of burning in throat/chest, suspected reflux; upcoming appointments with an Electrophysiologist and Neuromuscular Doctor for further evaluation. Note - also reported this using v-safe up until the weekly check ins were over


VAERS ID: 1416421 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Arizona  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-06-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210634361

Write-up: GUILLAIN-BARR? SYNDROME; This spontaneous report received from a patient concerned a patient of unspecified age, sex, race and ethnic origin. The patient''s height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose was not reported of frequency 1 total, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date in 2021, the patient was diagnosed with guillain-barr? syndrome, and has been hospitalized multiple times since April or May 2021. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of guillain-barr? syndrome was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0: This spontaneous report concerns a patient of unspecified age/sex/race/ethnicity was diagnosed with Guillain-Barr? Syndrome (GBS) after an unspecified duration from receiving Janssen COVID-19 vaccine. It was reported that the patient have been hospitalized multiple times. No other details reported. The information available precludes a complete and meaningful assessment. The information regarding other potential etiologies is insufficient, and the occurrence of her symptoms could represent background incidence of such events in the general population. Considering the temporal relationship, the events are assessed to have an indeterminate relationship with vaccination.


VAERS ID: 1423703 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-05-20
Onset:2021-05-29
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-06-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808982 / UNK - / IM

Administered by: Private       Purchased by: ?
Symptoms: Abdominal pain, Asthenia, Bell's palsy, Chest X-ray, Dysstasia, Facial paralysis, Gait disturbance, Guillain-Barre syndrome, Headache, Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture, Magnetic resonance imaging spinal, Muscular weakness, Neuralgia, Pain in extremity, Viral infection, Visual impairment
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Parkinson-like events (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Optic nerve disorders (broad), Demyelination (narrow), Lens disorders (broad), Retinal disorders (broad), Hearing impairment (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: finasteride
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: June 3, 2021 - Chest X-Ray June 7, 2021 - Lumbar Puncture June 8, 2021 - Lumbar MRI Final Diagnoses - DVT Prophylaxis, Facial neuropathy, Guillain-Barre Syndrome, Headache, Neuropathic pain, Weakness,
CDC Split Type:

Write-up: Beginning on May 29, 2021, symptoms began with persistent headache and numbness in legs and feet. By June 2, 2021, severe pain in legs, arms, abdomen with throbbing headache, barely able to stand up or walk. Went to emergency room evening of June 2, 2021, but was released with suspected viral infection and was told symptoms should subside. Symptoms got worse, with the addition of full facial paralysis and revisited same emergency room on June 6, 2021. Admitted to hospital and diagnosed with Guillian-Barre Syndrome. Spent six days in hospital receiving IGIV treatment over five nights. Released on June 12, 2021 with severe upper body weakness, limited leg weakness, constant headaches, Bell''s palsy and deteriorated vision. After two weeks of recovery, including doctor''s visits and physical therapy, still weakness in limbs and Bell''s palsy with deteriorated vision.


VAERS ID: 1424580 (history)  
Form: Version 2.0  
Age: 74.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-06-01
Onset:2021-06-06
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-06-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 206A21A / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 10 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: Shrimp, radish, ginger
Diagnostic Lab Data:
CDC Split Type:

Write-up: AIDP


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=7&SYMPTOMS=Guillain-Barre_syndrome_%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166